Familial Endocrine Syndromes

Published:October 01, 2014DOI:https://doi.org/10.1016/j.path.2014.08.008

      Abstract

      Endocrine tumors may present as sporadic events or as part of familial endocrine syndromes. Familial endocrine syndromes (or inherited tumor/neoplasm syndromes) are characterized by multiple tumors in multiple organs. Some morphologic findings in endocrine tumor histopathology may prompt the possibility of familial endocrine syndromes, and these recognized histologic features may lead to further molecular genetic evaluation of the patient and family members. Subsequent evaluation for these syndromes in asymptomatic patients and family members may then be performed by genetic screening.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Surgical Pathology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nosé V.
        • Paner G.P.
        • Greenson J.K.
        • et al.
        Diagnostic pathology: familial cancer syndromes.
        1st edition. Amirys Publishing, Inc, Manitoba (CA)2014
        • Carney J.A.
        Familial multiple endocrine neoplasia: the first 100 years.
        Am J Surg Pathol. 2005; 29: 254-274
        • Daly A.F.
        • Tichomirowa M.A.
        • Beckers A.
        The epidemiology and genetics of pituitary adenomas.
        Best Pract Res Clin Endocrinol Metab. 2009; 23: 543-554
        • Burlacu M.C.
        • Tichomirowa M.
        • Daly A.
        • et al.
        Familial pituitary adenomas.
        Presse Med. 2009; 38 ([in French]): 112-116
        • Daly A.F.
        • Tichomirowa M.A.
        • Beckers A.
        Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
        Horm Res. 2009; 71: 105-111
        • Daly A.F.
        • Beckers A.
        Update on the treatment of pituitary adenomas: familial and genetic considerations.
        Acta Clin Belg. 2008; 63: 418-424
        • Verloes A.
        • Stevenaert A.
        • Teh B.T.
        • et al.
        Familial acromegaly: case report and review of the literature.
        Pituitary. 1999; 1: 273-277
        • Dreijerink K.M.
        • Varier R.A.
        • van Beekum O.
        • et al.
        The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.
        Mol Cell Biol. 2009; 29: 5060-5069
        • Dreijerink K.M.
        • Lips C.J.
        • Timmers H.T.
        Multiple endocrine neoplasia type 1: a chromatin writer's block.
        J Intern Med. 2009; 266: 53-59
        • Dreijerink K.M.
        • Hoppener J.W.
        • Timmers H.M.
        • et al.
        Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
        Nat Clin Pract Endocrinol Metab. 2006; 2: 562-570
        • Falchetti A.
        • Marini F.
        • Luzi E.
        • et al.
        Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors.
        Genet Med. 2009; 11: 825-835
        • Capella C.
        • Riva C.
        • Leutner M.
        • et al.
        Pituitary lesions in multiple endocrine neoplasia syndrome (MENS) type 1.
        Pathol Res Pract. 1995; 191: 345-347
        • Nosé V.
        • Erickson L.A.
        • Tischler A.S.
        • et al.
        Diagnostic pathology: endocrine.
        1st edition. Amirsys, Salt Lake City(UT)2012
        • Trouillas J.
        • Labat-Moleur F.
        • Sturm N.
        • et al.
        Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
        Am J Surg Pathol. 2008; 32: 534-543
        • O'Brien T.
        • O'Riordan D.S.
        • Gharib H.
        • et al.
        Results of treatment of pituitary disease in multiple endocrine neoplasia, type I.
        Neurosurgery. 1996; 39 ([discussion 278–9]): 273-278
        • Stratakis C.A.
        • Kirschner L.S.
        • Carney J.A.
        Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.
        J Clin Endocrinol Metab. 2001; 86: 4041-4046
        • Bertherat J.
        Carney complex (CNC).
        Orphanet J Rare Dis. 2006; 1: 21
        • Horvath A.
        • Bossis I.
        • Giatzakis C.
        • et al.
        Large deletions of the PRKAR1A gene in Carney complex.
        Clin Cancer Res. 2008; 14: 388-395
        • Stratakis C.A.
        • Carney J.A.
        • Lin J.P.
        • et al.
        Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2.
        J Clin Invest. 1996; 97: 699-705
        • Chahal H.S.
        • Chapple J.P.
        • Frohman L.A.
        • et al.
        Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
        Trends Endocrinol Metab. 2010; 21: 419-427
        • Tahir A.
        • Chahal H.S.
        • Korbonits M.
        Molecular genetics of the aip gene in familial pituitary tumorigenesis.
        Prog Brain Res. 2010; 182: 229-253
        • Tichomirowa M.A.
        • Daly A.F.
        • Beckers A.
        Familial pituitary adenomas.
        J Intern Med. 2009; 266: 5-18
        • Carling T.
        Molecular pathology of parathyroid tumors.
        Trends Endocrinol Metab. 2001; 12: 53-58
        • Waldmann J.
        • Lopez C.L.
        • Langer P.
        • et al.
        Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
        Br J Surg. 2010; 97: 1528-1534
        • Marini F.
        • Falchetti A.
        • Del Monte F.
        • et al.
        Multiple endocrine neoplasia type 2.
        Orphanet J Rare Dis. 2006; 1: 45
        • Santoro M.
        • Melillo R.M.
        • Carlomagno F.
        • et al.
        Molecular biology of the MEN2 gene.
        J Intern Med. 1998; 243: 505-508
        • Lakhani V.T.
        • You Y.N.
        • Wells S.A.
        The multiple endocrine neoplasia syndromes.
        Annu Rev Med. 2007; 58: 253-265
        • Bhadada S.K.
        • Rao D.S.
        Hyperparathyroidism-jaw tumor syndrome.
        Endocr Pract. 2009; 15 ([author reply: 277]): 276-277
        • Iacobone M.
        • Masi G.
        • Barzon L.
        • et al.
        Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
        Langenbecks Arch Surg. 2009; 394: 817-825
        • Stalberg P.
        • Carling T.
        Familial parathyroid tumors: diagnosis and management.
        World J Surg. 2009; 33: 2234-2243
        • Guarnieri V.
        • Scillitani A.
        • Muscarella L.A.
        • et al.
        Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance.
        J Clin Endocrinol Metab. 2006; 91: 2827-2832
        • Hannan F.M.
        • Nesbit M.A.
        • Christie P.T.
        • et al.
        Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene.
        Nat Clin Pract Endocrinol Metab. 2008; 4: 53-58
        • Mizusawa N.
        • Uchino S.
        • Iwata T.
        • et al.
        Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
        Clin Endocrinol (Oxf). 2006; 65: 9-16
        • Pollak M.R.
        • Chou Y.H.
        • Marx S.J.
        • et al.
        Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype.
        J Clin Invest. 1994; 93: 1108-1112
        • Hendy G.N.
        • Guarnieri V.
        • Canaff L.
        Calcium-sensing receptor and associated diseases.
        Prog Mol Biol Transl Sci. 2009; 89: 31-95
        • Hendy G.N.
        • D'Souza-Li L.
        • Yang B.
        • et al.
        Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
        Hum Mutat. 2000; 16: 281-296
        • Davies L.
        • Welch H.G.
        Increasing incidence of thyroid cancer in the United States, 1973-2002.
        JAMA. 2006; 295: 2164-2167
        • Richards M.L.
        Familial syndromes associated with thyroid cancer in the era of personalized medicine.
        Thyroid. 2010; 20: 707-713
        • Alsanea O.
        • Clark O.H.
        Familial thyroid cancer.
        Curr Opin Oncol. 2001; 13: 44-51
        • Alsanea O.
        Familial nonmedullary thyroid cancer.
        Curr Treat Options Oncol. 2000; 1: 345-351
        • Dotto J.
        • Nose V.
        Familial thyroid carcinoma: a diagnostic algorithm.
        Adv Anat Pathol. 2008; 15: 332-349
        • Nose V.
        Thyroid cancer of follicular cell origin in inherited tumor syndromes.
        Adv Anat Pathol. 2010; 17: 428-436
        • Nose V.
        Familial follicular cell tumors: classification and morphological characteristics.
        Endocr Pathol. 2010; 21: 219-226
        • Jelsig A.M.
        • Qvist N.
        • Brusgaard K.
        • et al.
        Hamartomatous polyposis syndromes: a review.
        Orphanet J Rare Dis. 2014; 9: 101
        • Harach H.R.
        • Soubeyran I.
        • Brown A.
        • et al.
        Thyroid pathologic findings in patients with Cowden disease.
        Ann Diagn Pathol. 1999; 3: 331-340
        • Laury A.R.
        • Bongiovanni M.
        • Tille J.C.
        • et al.
        Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
        Thyroid. 2011; 21: 135-144
        • Nose V.
        Familial non-medullary thyroid carcinoma: an update.
        Endocr Pathol. 2008; 19: 226-240
        • Zambrano E.
        • Holm I.
        • Glickman J.
        • et al.
        Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes.
        Endocr Pathol. 2004; 15: 55-64
        • Harach H.R.
        • Lesueur F.
        • Amati P.
        • et al.
        Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2.
        J Pathol. 1999; 189: 387-393
        • Half E.
        • Bercovich D.
        • Rozen P.
        Familial adenomatous polyposis.
        Orphanet J Rare Dis. 2009; 4: 22
        • Groen E.J.
        • Roos A.
        • Muntinghe F.L.
        • et al.
        Extra-intestinal manifestations of familial adenomatous polyposis.
        Ann Surg Oncol. 2008; 15: 2439-2450
        • Harb W.J.
        • Sturgis E.M.
        Differentiated thyroid cancer associated with intestinal polyposis syndromes: a review.
        Head Neck. 2009; 31: 1511-1519
        • Harach H.R.
        • Williams G.T.
        • Williams E.D.
        Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm.
        Histopathology. 1994; 25: 549-561
        • Stratakis C.A.
        • Courcoutsakis N.A.
        • Abati A.
        • et al.
        Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex).
        J Clin Endocrinol Metab. 1997; 82: 2037-2043
        • Kopp P.
        • Pesce L.
        • Solis S.J.
        Pendred syndrome and iodide transport in the thyroid.
        Trends Endocrinol Metab. 2008; 19: 260-268
        • Dossena S.
        • Rodighiero S.
        • Vezzoli V.
        • et al.
        Functional characterization of wild-type and mutated pendrin (SLC26A4), the anion transporter involved in Pendred syndrome.
        J Mol Endocrinol. 2009; 43: 93-103
        • Ishikawa Y.
        • Sugano H.
        • Matsumoto T.
        • et al.
        Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race.
        Cancer. 1999; 85: 1345-1352
        • Charkes N.D.
        On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds.
        Thyroid. 2006; 16: 181-186
        • Bakhsh A.
        • Kirov G.
        • Gregory J.W.
        • et al.
        A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer.
        Endocr Relat Cancer. 2006; 13: 475-483
        • Uchino S.
        • Noguchi S.
        • Kawamoto H.
        • et al.
        Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
        World J Surg. 2002; 26: 897-902
        • Alsanea O.
        • Wada N.
        • Ain K.
        • et al.
        Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
        Surgery. 2000; 128 ([discussion: 1050–41]): 1043-1050
        • McKay J.D.
        • Lesueur F.
        • Jonard L.
        • et al.
        Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
        Am J Hum Genet. 2001; 69: 440-446
        • Malchoff C.D.
        • Sarfarazi M.
        • Tendler B.
        • et al.
        Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
        J Clin Endocrinol Metab. 2000; 85: 1758-1764
        • Bignell G.R.
        • Canzian F.
        • Shayeghi M.
        • et al.
        Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
        Am J Hum Genet. 1997; 61: 1123-1130
        • Pacini F.
        • Castagna M.G.
        • Cipri C.
        • et al.
        Medullary thyroid carcinoma.
        Clin Oncol (R Coll Radiol). 2010; 22: 475-485
        • Kloos R.T.
        • Eng C.
        • Evans D.B.
        • et al.
        Medullary thyroid cancer: management guidelines of the American Thyroid Association.
        Thyroid. 2009; 19: 565-612
        • Libe R.
        • Fratticci A.
        • Bertherat J.
        Adrenocortical cancer: pathophysiology and clinical management.
        Endocr Relat Cancer. 2007; 14: 13-28
        • Libe R.
        • Bertherat J.
        Molecular genetics of adrenocortical tumours, from familial to sporadic diseases.
        Eur J Endocrinol. 2005; 153: 477-487
        • Haase M.
        • Willenberg H.S.
        Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes.
        Minerva Endocrinol. 2009; 34: 123-135
        • Choufani S.
        • Shuman C.
        • Weksberg R.
        Beckwith-Wiedemann syndrome.
        Am J Med Genet C Semin Med Genet. 2010; 154C: 343-354
        • Karakas Z.
        • Tugcu D.
        • Unuvar A.
        • et al.
        Li-Fraumeni syndrome in a Turkish family.
        Pediatr Hematol Oncol. 2010; 27: 297-305
        • Dahia P.L.
        • Ross K.N.
        • Wright M.E.
        • et al.
        A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.
        PLoS Genet. 2005; 1: 72-80
        • van Nederveen F.H.
        • Gaal J.
        • Favier J.
        • et al.
        An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
        Lancet Oncol. 2009; 10: 764-771
        • Jensen R.T.
        • Berna M.J.
        • Bingham D.B.
        • et al.
        Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.
        Cancer. 2008; 113: 1807-1843
        • Alexakis N.
        • Connor S.
        • Ghaneh P.
        • et al.
        Hereditary pancreatic endocrine tumours.
        Pancreatology. 2004; 4 ([discussion: 434–5]): 417-433
        • Ekeblad S.
        Islet cell tumours.
        Adv Exp Med Biol. 2010; 654: 771-789
        • Tisell L.E.
        • Ahlman H.
        Treatment of the pancreatic disease of multiple endocrine neoplasia type 1 (MEN 1).
        Acta Oncol. 1989; 28: 415-417
        • Hough D.M.
        • Stephens D.H.
        • Johnson C.D.
        • et al.
        Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings.
        AJR Am J Roentgenol. 1994; 162: 1091-1094